Integra LifeSciences Q1 revenue $380.8M, organic growth 4.6%; adj EPS $0.74 flat YoY

INTEGRA LIFESCIENCES HOLDINGS CORP

2023-Q1 EPS reported $0.29 revenue$380,846,000

Q1 revenues $380.8M, +1.1% reported, +4.6% organic vs Q1 2022.
GAAP EPS $0.29 vs $0.39 prior year; adjusted EPS $0.74 flat.
Codman Specialty Surgical $248.1M (+3.5% organic); Tissue Technologies $132.7M (+6.8% organic).
Full-year 2023 guidance reaffirmed: revenue $1,602-1,620M, adj EPS $3.43-3.51.
Initiated $150M accelerated share repurchase; amended credit facility extended to 2028.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

INTEGRA LIFESCIENCES HOLDINGS CORP reported the first quarter ended March 31, 2023 results: revenue $380.8 million, net income $24.2 million, EPS $0.29 per diluted share. Guidance reaffirmed.

Period: the first quarter ended March 31, 2023
Revenue: $380.8 million
Net income: $24.2 million
EPS: $0.29 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Total reported revenues of $380.8 million increased 1.1% on a reported basis and increased 4.6% on an organic basis compared to the prior year. The Company reported GAAP gross margin of 61.1%, compared to 62.1% in the first quarter of 2022. Adjusted gross margin was 67.3%, compared to 67.7% in the prior year. Adjusted EBITDA for the first quarter of 2023 was $92.3 million, or 24.2% of revenue, compared to $93.5 million million, or 24.8% of revenue, in the prior year. The Company reported GAAP net income of $24.2 million, or $0.29 per diluted share, in the first quarter of 2023, compared to a GAAP net income of $32.9 million, or $0.39 per diluted share, in the prior year.

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-23-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.